• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION PRECISE PRO RX CAROTID STENT SYSTEM; SELF EXPANDING STENTS (NIM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION PRECISE PRO RX CAROTID STENT SYSTEM; SELF EXPANDING STENTS (NIM) Back to Search Results
Model Number N/A
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/04/2016
Event Type  malfunction  
Manufacturer Narrative
Concomitant products: a 6f sheath introducer.Gtin#: (b)(4).The product is available for evaluation and testing; however, it has not been received to date.Additional information will be submitted within 30 days of receipt.
 
Event Description
During the use of a precise stent to the internal right carotid artery, it was reported that several attempts were made to deploy the stent however, unable to deploy.The target lesion was treated with another stent and the procedure was completed successfully.There was no patient injury reported.Upon removing the sds, it was noted that the stent was partially deployed.It is unknown if this occurred inside the patient or outside the patient.The product will be returned for analysis.The device was prepped per ifu and there was no anomalies noted during this time.There was nothing unusual noted about the stent delivery system prior to use.A 6f sheath introducer.The stent delivery system did not pass through any acute bends.There was no difficulty encountered while advancing/tracking the sds towards the lesion.There was no unusual force used at any time during the procedure.The lesion was described as "normal".
 
Manufacturer Narrative
The product has been returned for evaluation and testing; however, the engineering evaluation has not been completed.Additional information will be submitted within 30 days of receipt.
 
Manufacturer Narrative
Complaint conclusion: a report was received that the stent of a 10 x 40mm precise pro rx us carotid system could not be deployed.The device was removed and the procedure successfully completed with another stent delivery system (sds) with no reported patient injury.The event involved a patient undergoing a percutaneous intervention in a target lesion in the right internal carotid artery.The patient¿s vasculature was accessed with the use of a 6fr catheter sheath introducer.The site reported that the sds had been prepped according to the instructions for use (ifu) and that no anomalies were noted during this time.No difficulty was experienced while tracking the device to the target lesion.The sds did not have to pass through any acute bends and no unusual force was required at any time during the procedure.Several attempts to deploy the stent in the target lesion were unsuccessful.The device was removed and the procedure successfully completed with another sds with no reported patient injury.At some point after the device removal and before shipping the device for analysis, the site noted that the stent had partially deployed.One non-sterile precise pro rx us carotid syst was received coiled inside a plastic bag with the stent partially deployed by 2.0cm and the hemostasis valve open.No other damages were found on the received unit.Functional testing of the deployment process was successfully performed with no anomalies found.Dimensional analysis of the stroke length revealed that it was within specification.A review of the manufacturing records for this lot of products revealed that it met specification prior to release.The reported ¿sds - deployment difficulty-partial deployment¿ event was confirmed based on the results of the visual analysis.The cause of this event could not be conclusively determined during the analysis.According to the product ifu, users are instructed to ensure that the sds outside the patient remains flat and straight.Users are instructed to unlock the hemostasis valve prior to stent deployment.They are to ensure that the sheath introducer or guiding catheter does not move during deployment.The ifu further instructs users to initiate stent deployment by retracting the outer sheath while holding the inner shaft in a fixed position.Deployment is complete when the outer sheath marker passes the proximal inner shaft stent marker.It is difficult to draw a clinical conclusion between the device and the event based on the information available.However handling factors (handling of the sds prior to shipping it) may have contributed to it.Neither the device history record review nor the product analysis suggests that the reported event was related to the manufacturing process.A risk assessment and investigation has been initiated to address these types of issues.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX CAROTID STENT SYSTEM
Type of Device
SELF EXPANDING STENTS (NIM)
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL
Manufacturer Contact
cecil navajas
circuito interior norte #1820
juarez chihuahua 32580
MX   32580
7863133880
MDR Report Key5605352
MDR Text Key43539278
Report Number9616099-2016-00200
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 04/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2017
Device Model NumberN/A
Device Catalogue NumberPC1040RXC
Device Lot Number17369479
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/29/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/05/2016
Initial Date FDA Received04/25/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received05/20/2016
05/25/2016
Date Device Manufactured11/30/2015
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-